1 / 11

Global Fund Grant Renewals Process

Global Fund Grant Renewals Process. Regional Workshop on NSP for TB Control Moldova, 8 th October 2012. Grant Renewals Policy. The renewals policy and process applies to all RCC, Phase 2 and SSF grants, including those derived from NSA and HSS (cross-cutting and HSFP) proposals.

rosina
Télécharger la présentation

Global Fund Grant Renewals Process

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global Fund Grant Renewals Process Regional Workshop on NSP for TB Control Moldova, 8th October 2012

  2. Grant Renewals Policy • The renewals policy and process applies to all RCC, Phase 2 and SSF grants, including those derived from NSA and HSS (cross-cutting and HSFP) proposals. • Before the end of each Implementation Period, grants are required to undergo a renewals review to assess program results and performance, identify opportunities for reprogramming towards more strategic interventions, and determine whether funding for the next implementation period will be recommended to the Board. • Eligibility Criteria: Effective 1 January 2012, the following country eligibility rules apply to renewals. The GF will issue a Renewals Eligibility List for each calendar year. • CCM eligibility criteria.

  3. Strategic Objective 2.2: Refocus Existing Investments • THE GLOBAL FUND STRATEGY 2012-2016: INVESTING FOR IMPACT

  4. Strategic Refocusing of Existing Investments: Rationale • •Significant amount of resources approved in proposals but as yet uncommitted or unused, e.g., in EECA: • $575 million approved for TB, • $445 million have already been disbursed to countries for TB programs, • $760 millioncommitted funding (renewal) for 20 countries. • •Interventions that may no longer be appropriate e.g., by time of grant renewal, original Board-approved proposal is [3]+ years old • •Material reprogramming is rare: less than [5%] of grants renewals include reprogramming[only 26 reprogramming requests out of 500 renewals from 2006-11]

  5. Global Fund Grant Renewals • Up to 3-year “checkpoints” of achievements against the objectives and goals of the Proposal in terms of “programmatic progress and public health impact”. • Opportunity to ensure effectiveness of our investments in a disease program, review implementation arrangements and/or reprogram. • Periodic Reviews – and whenever possible all renewals - look at the entirety of GF funding in a component program (all PRs).

  6. Global Fund Grant Renewals • •The assessment conducted at the time of grant renewals focuses on: • i. progress towards proposal goals and disease impact; • ii. PR performance; and • iii. identified grant or program-level risks, if any. • Note: The GF will not seek to directly attribute disease impact to a specific PR. • •The additional financial commitment recommendation to the Board per PR will include: • i. Performance rating; • ii. Recommendation category (with corresponding conditions, if any); and • iii. Recommended additional financial commitment amount.

  7. PERFORMANCE BASED FUNDING METHODOLOGY AT RENEWALS

  8. Examples of High-level Questions for Renewal Panel Discussion: • Are resources focused on highest impact interventions? • Are we investing strategically to maximize health impact (taking into account the donor landscape in-country)? • Is the latest normative guidance adequately reflected in the program design?

  9. Examples of High-level Questions for Renewal Panel Discussion (cont’d): • Is this program appropriate to the country’s disease epidemiology and health system’s context? • If not appropriate, what needs to change? Are there any areas we have missed / critical gaps? • Are reprogramming suggestions adequate? • What contributions could the in country technical partners make to address the key conditions and critical issues?

More Related